Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiotrophin 2, pseudogene (CTF2P) represents the human ortholog of the murine cytokine neuropoietin (cardiotrophin-2). While neuropoietin is a functional cytokine in mice and other mammals—acting via the CNTF receptor complex, LIF receptor, and gp130 to promote neural survival and proliferation—human CTF2P is rendered nonfunctional by an 8-base pair deletion that disrupts the coding sequence. As a result, CTF2P does not produce an active protein, has no known physiological or pathological functions, is not associated with any disease, and is not considered a direct therapeutic target in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiotrophin 2, pseudogene (CTF2P).